RecruitingNCT06524167

RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer

A Real-world Study of Adjuvant Radiotherapy in High Recurrence Risk Locally Advanced Thyroid Cancer


Sponsor

Fudan University

Enrollment

80 participants

Start Date

Jul 2, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study is a real-world study to observe the role of adjuvant radiotherapy in locally advanced recurrent high-risk thyroid cancer. The study included thyroid cancer that requires adjuvant radiotherapy to increase local control rate, excluding undifferentiated cancer. Local-regional recurrence free survival is the primary endpoint of the study.


Eligibility

Min Age: 14 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is examining how well adjuvant radiation therapy (radiation given after surgery) works in patients with locally advanced thyroid cancer who are at high risk of the cancer coming back. Researchers are collecting real-world data to better understand outcomes for these patients. **You may be eligible if...** - You are between 14 and 80 years old - You have a confirmed thyroid cancer diagnosis (including differentiated, medullary, or poorly differentiated types) - You are at high risk of local recurrence — for example, because surgery could not fully remove the cancer (not R0 resection), the cancer invaded nearby structures (esophagus, trachea, nerves), or you had a poor-prognosis cancer type **You may NOT be eligible if...** - Your thyroid cancer has not yet been surgically treated (only biopsied) - You have had or currently have another active cancer within the past 5 years (some cured local cancers may be acceptable) - You previously received radiation to your head or neck - You are pregnant or breastfeeding - You have claustrophobia preventing you from tolerating radiation therapy - Other serious illnesses or conditions make participation unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONadjuvant radiotherapy

The patients would receive external radiation therapy within 6 weeks after surgery, using intensity-modulated radiation therapy (IMRT) or volume modulated radiation therapy (VMAT) techniques. 6MV-X-ray irradiation. Conventional segmented irradiation is used, once a day, five times a week, with a segmented dose of 2Gy per dose.


Locations(1)

Fudan University Shanghai Cancer Center

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06524167


Related Trials